Ensartinib Uses, Dosage, Side Effects and more
Ensartinib is under investigation in clinical trial NCT03420508 (Treating Patients With Melanoma and ALK Alterations With Ensartinib).
| Attribute | Details |
|---|---|
| Trade Name | Ensartinib |
| Generic | Ensartinib |
| Ensartinib Other Names | Ensartinib |
| Type | |
| Formula | C26H27Cl2FN6O3 |
| Weight | Average: 561.44 Monoisotopic: 560.1505723 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
